Improving drug safety and effectiveness for mothers and children
Official title: NICHD PEDIATRIC AND MATERNAL RESOURCE CENTER: BRIDGING PHARMACOLOGY AND THE REAL WORLD - BPCA PTN
Funded at Duke University · NIH-11196836 · Data updated 2026-11-12
This study is looking at how different medications and medical devices can be safer and more effective for moms and their kids during pregnancy and early childhood, so families can have better treatment options that fit their needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | September 23, 2024 |
| Project end | September 22, 2028 |
| Funding year | 2024 |
| Award (this year) | $343,265 |
| NIH project number | 275201800003I-0-759402400001-1 |
| Project ID | NIH-11196836 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include pregnant women, new mothers, infants, and children up to adolescence who may require therapeutic interventions.
✕Less likely to help
Patients who are not pregnant or do not have children may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the understanding of how medications affect mothers and children, particularly during pregnancy and early childhood. It aims to evaluate and improve the safety and efficacy of various therapeutics, including drugs and medical devices, through advanced research methods. By utilizing cutting-edge technologies and data science, the project seeks to develop better treatment strategies tailored to the unique needs of pediatric and maternal populations. Patients may benefit from improved therapeutic options that are specifically designed for their age and health conditions.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective medications for mothers and children.
How similar studies have gone: Previous research has shown success in improving pediatric pharmacology through similar innovative approaches, indicating a promising path for this project.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Benjamin, Daniel — Duke University
- Study coordinator: Benjamin, Daniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.